Planet Labs PBC
PL · NYSE
Analyst ratings
strong_buy · 10 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 14, 2026 | Goldman Sachs | Maintains | Neutral | $25.00 |
| July 1, 2026 | Wedbush | Reiterates | Outperform | $50.00 |
| June 5, 2026 | Craig-Hallum | Maintains | Buy | $49.00 |
| June 5, 2026 | Wedbush | Reiterates | Outperform | $50.00 |
| June 5, 2026 | Needham | Maintains | Buy | $53.00 |
| May 14, 2026 | Wedbush | Maintains | Outperform | $50.00 |
| April 20, 2026 | Goldman Sachs | Maintains | Neutral | $20.00 |
| April 2, 2026 | Citigroup | Maintains | Buy | $35.00 |
| March 25, 2026 | Morgan Stanley | Maintains | Equal-Weight | $35.00 |
| March 20, 2026 | Clear Street | Maintains | Buy | $34.00 |
| March 20, 2026 | Cantor Fitzgerald | Maintains | Overweight | $40.00 |
| March 20, 2026 | Wedbush | Maintains | Outperform | $40.00 |
| March 20, 2026 | Needham | Maintains | Buy | $40.00 |
| January 14, 2026 | Morgan Stanley | Maintains | Equal-Weight | $26.00 |
| January 13, 2026 | Citigroup | Maintains | Buy | $30.00 |
| January 13, 2026 | Wedbush | Maintains | Outperform | $28.00 |
| December 29, 2025 | Clear Street | Maintains | Buy | $22.00 |
| December 12, 2025 | Morgan Stanley | Maintains | Equal-Weight | $20.00 |
| December 11, 2025 | Deutsche Bank | Maintains | Buy | $17.00 |
| December 11, 2025 | Clear Street | Maintains | Buy | $16.00 |
| December 11, 2025 | Wedbush | Maintains | Outperform | $20.00 |
| December 11, 2025 | Needham | Maintains | Buy | $22.00 |
| December 4, 2025 | Clear Street | Maintains | Buy | $14.00 |
| October 21, 2025 | Deutsche Bank | Maintains | Buy | $16.00 |
| October 20, 2025 | Needham | Maintains | Buy | $16.00 |
| October 17, 2025 | Cantor Fitzgerald | Maintains | Overweight | $20.00 |
| October 2, 2025 | Wedbush | Maintains | Outperform | $17.00 |
| September 15, 2025 | Clear Street | Maintains | Buy | $12.00 |
| September 9, 2025 | JMP Securities | Maintains | Market Outperform | $11.00 |
| September 9, 2025 | Needham | Maintains | Buy | $12.00 |
Valuation: Deeply undervalued opportunity vs. dangerously overpriced on fundamentals
With Planet Labs trading below the consensus fair value of $40.00 and analysts like Needham setting a $53 price target, the stock is seen as significantly undervalued. The $230 million JSAT contract with front-loaded cash payments is expected to drive meaningful cash flow accretion and accelerate the path to free cash flow positivity.
Despite the optimistic narrative fair value, Planet Labs trades at a P/S ratio of 33.3x — far above the industry average of 0.9x and even the more generous peer-based fair ratio of 7.5x. The Simply Wall St DCF model estimates intrinsic value at just $2.53 per share, suggesting severe overvaluation for a company forecast to remain unprofitable for at least three more years.
Path to profitability: Improving trajectory vs. persistent losses with no near-term resolution
Planet Labs reported 42.1% year-over-year revenue growth and a smaller-than-expected loss in its latest earnings, demonstrating meaningful operational progress. Forecasts show the net loss per share narrowing sharply from $0.80 to $0.46, signaling that the company is on a credible trajectory toward eventual profitability.
Despite revenue momentum, Planet Labs still carries negative profitability metrics and analysts expect a loss of $0.92 EPS for the current fiscal year. Goldman Sachs maintains a neutral rating with a $22–$25 price target, reflecting skepticism that the company can translate top-line growth into sustainable earnings within a foreseeable timeframe.
Competitive positioning: Unique Earth observation advantage vs. mounting pressure from rivals like SpaceX
The successful Pelican-11 satellite launch, addition of nearly 100 satellites within two years, and inclusion in the Russell 1000 and Russell Midcap indexes reflect growing institutional confidence. Wedbush initiated coverage with an 'outperform' rating and a $50 target, citing Planet Labs' expanding global capacity and revisit rates as strong competitive differentiators.
Planet Labs shares dropped sharply amid the SpaceX IPO, which analysts flagged as a direct competitive threat to its Earth observation business. Deutsche Bank responded by cutting its price target from $38 to $36, and New Street Research initiated coverage with a 'sell' rating and a $28 target, citing concerns about Planet Labs' ability to defend its market position against better-capitalized rivals.